Clearmind Medicine CMND 深 沪
已收盘 12-12 16:00:00 美东时间
0.0743
+0.003
+3.63%
华盛通- 最 高0.08
- 今 开0.079
- 成交量 1147.15万股
- 最 低 0.0716
- 昨 收 0.0717
- 总市值 40.62万
- 52周最高 2.18
- 市盈率 静 --
- 换手率 209.85%
- 52周最低 0.0661
- 委 比 -21.57%
- 总股本 546.64万
- 历史最高 183.00
- 量 比 1.18
- 振 幅 11.72%
- 历史最低 0.0661
- 每 手 1
- 风险率 0.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Are Shares Of Atossa Therapeutics Up Today?
Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock is trading higher on Thursday. Here's what investors need to know.
12-12 01:26
Clearmind Medicine shares are trading lower after the company announced a 1-for-40 reverse share split.
Clearmind Medicine shares are trading lower after the company announced a 1-for...
12-11 05:30
Clearmind Medicine Announces 1-for-40 Reverse Share Split
Clearmind Medicine Inc. (NASDAQ: CMND) announces a 1-for-40 reverse share split to regain compliance with the Nasdaq Minimum Bid Price Rule, effective December 15, 2025. The split was approved by the board on November 12, 2025. This will reduce the outstanding common shares from 59,991,852 to approximately 1,499,796, with fractional shares rounded up. All outstanding options and warrants will be proportionally adjusted. The company focuses on dev...
12-10 21:15
DigitalBridge, Sezzle jump, American Bitcoin, WRB slide: week's financials wrap
This week's biggest financials gainers were led by an alternative asset manager in takeover talks, while the biggest loser was a Trump family-tied bitcoin (BTC-USD) accumulation platform company. Digi...
12-06 23:10
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers GT Biopharma (NASDAQ:GTBP) shares moved upwards by 6.6% to $0.65 durin...
12-06 05:05
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial
Clearmind Medicine Inc. recently reported three key milestones in its FDA-approved Phase I/IIa clinical trial for CMND-100, an oral therapy targeting Alcohol Use Disorder (AUD). These include positive results from the first cohort, DSMB approval to continue the trial, and the启动of enrollment at a new clinical site in Israel. AUD affects over 28 million adults in the U.S., causing significant societal and economic impacts. CMND-100 aims to reduce a...
12-01 13:56
Why Did Clearmind Medicine Shares Jump 7% In Pre-Market Trading?
Clearmind Medicine rose 7.09% in pre-market trading after announcing enrollment of first patient in trial for alcohol use disorder.
11-26 17:32
Clearmind Launches New Trial For Non-Hallucinogenic Drug Aiming To Curb Alcohol Addiction
Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics to
11-20 19:04
Neurothera Labs and Clearmind Medicine File Patent for Innovative Depression Treatment
NeuroThera Labs Inc. ( ($TSE:NTLX) ) has issued an announcement. Neurothera Lab...
11-19 22:07
Clearmind Medicine (CMND) Stock Soars Thursday: What's Going On?
Clearmind Medicine Inc (NASDAQ:CMND) shares are trading higher on Thursday. Here's a look at what you need to know.
11-14 02:20
